THE TOTAL POWER OF THE HEART AS A PROMISING PARAMETER FOR ASSESSING THE FUNCTIONAL STATE OF THE PATIENT DURING AN OBJECTIVE STRUCTURED CLINICAL EXAMINATION: GNOSEOLOGY, CLINICAL SIGNIFICANCE

Abstract

This study reveals the clinical value of the parameter of the total power of the heart in assessing the functional state of the patient. The article is devoted to the expediency of using the method of short recording of heart rhythm variability in Objective Structured Clinical Examination.
 The purpose of the study was to investigate the total power in patients with noncommunicable diseases based on the results of recording a short record of heart rhythm variability as a promising parameter for assessing the functional state during an Objective Structured Clinical Examination.
 Materials and methods. An analysis of the total power was carried out based on the data of the short record of heart rhythm variability in 229 people. 43 persons were comorbid patients with coronary heart disease, 111 persons were young functionally healthy non-athletes, 75 persons were professional young athletes.
 Results. The diagnostic value of the parameter of the total power of the heart was proved. 23% and 21% of patients with non-stationary heart rhythm in the background and orthostatic modes were found. A decrease in total power of various degrees was established in patients, in contrast to control groups.
 Conclusions. 1) The total power of cardiac activity is a promising, diagnostically valuable parameter for assessing the patient's functional state during an Objective Structured Clinical Examination. 2) Now all the conditions have been formed for the widespread introduction of the method of short recording of heart rhythm variability in the practice of internal medicine doctors.3) The method of short recording of heart rhythm variability can be recommended for use in the clinical examination of patients as a device for improving the individual work of a doctor in order to determine the individual characteristics of the functioning of the heart, determine the risk of cardiac death, and early preclinical diagnosis of emerging pathology.